Emford Equity Partners
VC Fund
Emford Equity Partners is a VC fund focused on Automotive and Health Care. Emford Equity Partners
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Emford Equity Partners invests in
Stages Emford Equity Partners invests in
Countries Emford Equity Partners invests in
Round sizes
Round size
- Seed
- $1M–$6.8M
- Series A
- $2.1M–$8M
- Series B
- $9.5M–$15M
Investment Focus
Industry
- Automotive 3 (33%)
- Health Care 3 (33%)
- Medical 2 (22%)
- Autonomous Vehicles 2 (22%)
- Artificial Intelligence 2 (22%)
Stage
- Seed 3 (33%)
- Series A 3 (33%)
- Series B 2 (22%)
- Venture - Series Unknown 1 (11%)
Country
- South Korea 7 (78%)
- United States 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique drug molecule diversity technology, the image-based screening technology using the unique fluorescent skeleton probe, and the target protein identification technology in the initial drug development stage. We are currently exploring anddeveloping new drug candidates using these three core technologies, and we will continue to accelerate the development of new drugs and increase the success rate through strategic cooperation research with domestic and overseas research institutes and pharmaceutical institutions. ' | $21.4M / Venture - Series Unknown / May 11, 2026 | ||
| RideNow: An app-based platform for test drives and vehicle purchases. RideCare: App-based B2B and B2C vehicle care services. RideContents: Educational services for automotive brands, aimed at enhancing the quality of manufacturers and importers. RideOn: After-sales management services for electric vehicle chargers. | Seed / Mar 23, 2023 | ||
| SOS Lab, a LiDAR development company focusing on core technology for self-driving cars, plans to present its differentiated hybrid LiDAR system, the SL-1SOS LAB's long-range, hybrid scanning design combines the advantages of the widely-used motor scanning system with a solid-state MEMS mirror, and will be offered at a much lower price pointcompared to traditional LiDAR products on the market today. SL-1 is expected to play an important role in the popularization and accessibility of self-driving cars.In addition to the SL-1, SOS LAB offers two additional LiDAR products designed to integrate safe, effective, and affordable LiDAR technology into various industries: the GL-3 for factory automation and robotics, and the TL-3 for security and automatic doors. SOS LAB is also focusing on combining hardware-based sensors and AI-based object recognition and tracking technology using 3D point cloud LiDAR data, and plans to provide LiDAR data space/object recognition solutions for self-driving vehicles.SOS LAB includes jointly developing their hybrid LiDAR with a partner automotive electronic equipment field company, continuing to develop the next generation of Solid-State-LiDAR with global semiconductor companies to overstep the limits of OPA-method LiDAR, and extending the global footprint of SOS LAB to provide the smartest solutions for self-driving and ADAS markets. SOS LAB is planning to enter global markets based on its R&D centers in Seoul and Gwangju and business centers in Silicon Valley. | $14.8M / Series B / Jul 27, 2022 | ||
| Ride Now is an app-based EV test drive service. It is an electric vehicle comparative experience portal. Ride works in the automobile sector as an EV pre-sales, sales, and vehicle management specialist to expedite the world's transition to sustainable energy transportation. | $1M / Seed / Jan 01, 2022 | ||
| AZothBio is an artificial intelligence-based drug delivery system platform and new drug candidate discovery service. | $5.5M / Series A / Dec 10, 2020 | ||
| G2GBIO operates to supply good medicines to patients all over the world and practice. | $9.5M / Series B / Jul 24, 2020 | ||
| ThorDrive is a company that develops software solutions related to automated and unmanned technology. ThorDrive provides an automated and unmanned platform and associated products as well as intellectual properties that can be applied to other areas. | $6.8M / Seed / Apr 22, 2020 | ||
| SOS Lab, a LiDAR development company focusing on core technology for self-driving cars, plans to present its differentiated hybrid LiDAR system, the SL-1SOS LAB's long-range, hybrid scanning design combines the advantages of the widely-used motor scanning system with a solid-state MEMS mirror, and will be offered at a much lower price pointcompared to traditional LiDAR products on the market today. SL-1 is expected to play an important role in the popularization and accessibility of self-driving cars.In addition to the SL-1, SOS LAB offers two additional LiDAR products designed to integrate safe, effective, and affordable LiDAR technology into various industries: the GL-3 for factory automation and robotics, and the TL-3 for security and automatic doors. SOS LAB is also focusing on combining hardware-based sensors and AI-based object recognition and tracking technology using 3D point cloud LiDAR data, and plans to provide LiDAR data space/object recognition solutions for self-driving vehicles.SOS LAB includes jointly developing their hybrid LiDAR with a partner automotive electronic equipment field company, continuing to develop the next generation of Solid-State-LiDAR with global semiconductor companies to overstep the limits of OPA-method LiDAR, and extending the global footprint of SOS LAB to provide the smartest solutions for self-driving and ADAS markets. SOS LAB is planning to enter global markets based on its R&D centers in Seoul and Gwangju and business centers in Silicon Valley. | $8M / Series A / Mar 30, 2020 | ||
| Humanscape is a rare disease health-tech company working to bring better chances of cure for patients. By collecting comprehensive patient health data from genotype, clinical to phenotype data and systematically compiling it into a complete, ready-to-use data set, pharmaceuticals and researchers can significantly reduce both time and cost for newdrug development. | $2.1M / Series A / Sep 18, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Emford Equity Partners invest in?
Emford Equity Partners invests primarily in Automotive, Health Care and Medical startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Emford Equity Partners invest in?
Emford Equity Partners typically joins rounds of $1M–$6.8M at Seed, $2.1M–$8M at Series A and $9.5M–$15M at Series B. These are whole funding-round sizes, not Emford Equity Partners's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Emford Equity Partners took part in.
When did Emford Equity Partners last invest?
The most recent investment recorded for Emford Equity Partners closed in May 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
